Skip to main content

2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS

This is a preview of subscription content, access via your institution.

Data availability

All clinical data and images are available and accessible on request.

References

  1. 1.

    Crump M, Neelapu SS, Farooq U, Van Den Neste E, Kuruvilla J, Westin J, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130:1800–8. https://doi.org/10.1182/blood-2017-03-769620.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Cabanillas F, Shah B. Advances in diagnosis and management of diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2017;17(12):783–96. https://doi.org/10.1016/j.clml.2017.10.007.

  3. 3.

    Neelapu SS, Locke FL, Bartlett NL, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N Engl J Med. 2017;377:2531–44. https://doi.org/10.1056/NEJMoa1707447.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Rubin DB, Husain HD, Ali BA, Karen L, Sarah L, et al. Neurological toxicities associated with chimeric antigen receptor T-cell therapy. Brain. 2019;142(5):1334–48. https://doi.org/10.1093/brain/awz053.

    Article  PubMed  Google Scholar 

  5. 5.

    Shah NN, Sarah JN, Drew AT, Michael DF, Wei-Ting H, Noelle F, et al. Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor –T-cell therapy in B-cell non-hodgkin lymphomas. Cytotherapy. 2018;20(12):1415–8. https://doi.org/10.1016/j.jcyt.2018.10.003.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Ruff A, Hatcher JB, Austin RP, Esin CN, Mitchell EH, Sunita DN, et al. 18F-Fluorodeoxyglucose positron emission tomography/computed tomography following chimeric antigen receptor T-cell therapy in large b-cell lymphoma. Mol Imag Biol. 2021. https://doi.org/10.1007/s11307-021-01627-8.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Andrea Paccagnella.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of interest

The authors declare no competing interests.

Informed consent

Informed consent was obtained from the subject included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Image of the month.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Paccagnella, A., Farolfi, A., Casadei, B. et al. 2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS. Eur J Nucl Med Mol Imaging (2021). https://doi.org/10.1007/s00259-021-05562-2

Download citation